Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment
To learn more about the Hypertrophic Cardiomyopathy Center, please visit https://cle.clinic/3aYKgaP
Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.
Видео Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment канала Cleveland Clinic
Hypertrophic Cardiomyopathy (HCM) in the majority of cases causes restriction of blood flow in the outflow tract of the heart caused by systolic anterior motion (SAM) of the mitral valve. Dr. Steve Nissen talks with cardiologist Dr. Milind Desai and surgeon Dr. Nick Smedira, Directors of the Hypertrophic Cardiomyopathy Center about current treatment options, such as medications and surgical therapy, what we have learned from years of experience with HCM at Cleveland Clinic, and a new innovative medication that is being researched that may reduce the need for – or delay surgery.
Видео Hypertrophic Cardiomyopathy (HCM): Innovative Options for Treatment канала Cleveland Clinic
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Hypertrophic Cardiomyopathy: Novel Predictors of Outcome (CHRISTOPHER M. KRAMER, MD) March 22, 2018Hypertrophic Cardiomyopathy (HCM) Mechanism of Disease VideoCOVID-19 Facts & MisinformationOverview of Medical Therapies for Hypertrophic Cardiomyopathy (HCM): Dr. Mark SherridOrthopaedic Hip Replacement SurgeryAtrial Fibrillation Treatment at Cleveland ClinicHypertrophic cardiomyopathy - signs and symptoms, causes, pathophysiology, treatmentJames Spudich (Stanford) 4: Myosin mutations and hypertrophic cardiomyopathyMedical Treatment of Hypertrophic Cardiomyopathy - Andrew Wang, MDAscending Aortic Aneurysm Surgery: When To Have SurgeryAdvanced EKGs - Sudden Cardiac Death (Hypertrophic cardiomyopathy, ARVD, Brugada syndrome, and CPVT)Orthopaedic Knee Replacement SurgeryHow to Decide What Valve is Right for YouCardiomyopathy, animationWhy CMR Webinar 9: CMR in hypertrophic cardiac conditions Part II¿infiltrative cardiomyopathy? ¿hypertrophic cardiomyopathy?29-year-old Overcomes COVID-19 and Cardiac Arrest on VentilatorHCM Advocacy with Lisa Salberg, Founder of the Hypertrophic Cardiomyopathy AssociationG. Jay Bishop, MD | Cleveland Clinic Heart, Vascular & Thoracic InstituteNephrology & Hypertension Fellowship Program